South Korea to review Novavax vaccine authorization application

2021-05-12 15:50:00

Novavax's application to Europe and the United States for emergency authorization to use the Coronavirus vaccine has been postponed to the third quarter.

Korean companies are preparing the information required for the application for emergency authorization to use the vaccine. The Ministry of Food and Drug Safety will accept the relevant information and review it promptly.

Novavax Vaccine Novavax covid-19 South Korea

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tencent Holdings repurchased 3.93 million shares for HK$1.5 billion on January 7
                            2025-01-07

                                    Ireland recorded a 12.8 billion euro fiscal surplus last year due to the "Apple tax" ruling
                            2025-01-07

                                    Ministry of Industry and Information Technology: Promoting technical verification of 10G optical network and artificial intelligence integration
                            2025-01-07

                                    Tencent's major shareholder Prosus reduced its stake in Tencent Holdings from 24.01% to 23.99% on January 6.
                            2025-01-07

                                    U.S. chip stocks rose before the market opened, with Nvidia up 0.6%
                            2025-01-07